"A. Yes. Thanks, Mark. So I'll just quickly take it. We have rights in US, Europe and a number of other ex US markets. BeiGene keeps rights in parts of Asia and Latin America. The clinical trial portfolio \u2013 clinical trials currently being conducted are already conducted with support filings in a full range of indications. So second line in lung which they hope to complete this year, first-line lung, colorectal cancer, head and neck. Susanne, are there others that I'm missing?"